Skip to main content

Advertisement

Log in

Clinical Outcomes, Trends in Weight, and Weight Loss Strategies in Patients With Obesity After Durable Ventricular Assist Device Implantation

  • Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (A. Hasan, Section Editor)
  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To discuss clinical outcomes, changes in weight, and weight loss strategies of patients with obesity post left ventricular assist device (LVAD) implantation.

Recent Findings

Despite increased complications in patients with obesity after LVAD implantation, survival is comparable to patients without obesity. A minority of patients with obesity lose significant weight and become eligible for heart transplantation after LVAD implantation. In fact, a great majority of such patients gain weight post-implantation.

Summary

Obesity by itself should not be considered prohibitive for LVAD therapy but, rather, should be incorporated into the overall risk assessment for LVAD implantation. Concerted strategies should be developed to promote sustainable weight loss in patients with obesity and LVAD to improve quality of life, eligibility, and outcomes after heart transplantation. Investigation of the long-term impact of weight loss on patients with obesity with LVAD is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalance of obesity among adults and youth: Unites States, 2015-2016. NCHS Data brief. 2017;288:1–8.

    Google Scholar 

  2. • Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50 This study describes the nationwide prevalance and demographic variations of obesity in the United States.

    Article  PubMed  Google Scholar 

  3. Ahmad FS, Ning H, Rich JD, Yancy CW, Lloyd-Jones DM, Wilkins JT. Hypertension, obesity, diabetes, and heart failure-free survival: the cardiovascular disease lifetime risk pooling project. JACC Heart Fail. 2016;4(12):911–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Alpert MA, Terry BE, Mulekar M, Cohen MV, Massey CV, Fan TM, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80(6):736–40.

    Article  CAS  PubMed  Google Scholar 

  5. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13.

    Article  PubMed  Google Scholar 

  6. Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e535–e78.

    Article  PubMed  Google Scholar 

  7. Joyce E, Lala A, Stevens SR, Cooper LB, AbouEzzeddine OF, Groarke JD, et al. Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations. JACC Heart Fail. 2016;4(12):923–31.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zenilman A, Pechman D, Moran-Atkin E, Choi J, Camacho D. Bariatric surgery in patients with left ventricular assist devices: a safe and effective method of weight loss as a gateway to heart transplantation. Surg Obes Relat Dis. 2019;15(10):1780–4.

    Article  PubMed  Google Scholar 

  9. Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016;35(1):1–23.

    Article  PubMed  Google Scholar 

  10. Clerkin KJ, Naka Y, Mancini DM, Colombo PC, Topkara VK. The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices. JACC Heart Fail. 2016;4(10):761–8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. • Jaiswal A, Truby LK, Chichra A, Jain R, Myers L, Patel N, et al. Impact of obesity on ventricular assist device outcomes. J Card Fail. 2020;26(4):287–97 This is the largest study evaluating the outcomes of ventricular assist devices in obese population. This study, also, demonstarted that significant weight loss following ventricular assist device implantation was only achieved by a small proportion of patients.

    Article  PubMed  Google Scholar 

  12. Kiernan MS, Najjar SS, Vest AR, Birks EJ, Uriel N, Ewald GA, et al. Outcomes of severely obese patients supported by a centrifugal-flow left ventricular assist device. J Card Fail. 2020;26(2):120–7.

    Article  PubMed  Google Scholar 

  13. Dhesi P, Simsir SA, Daneshvar D, Rafique A, Phan A, Schwarz ER. Left ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure. Ann Transplant. 2011;16(1):5–13.

    PubMed  Google Scholar 

  14. Yanagida R, Czer LS, Mirocha J, Rafiei M, Esmailian F, Moriguchi J, et al. Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy. Transplant Proc. 2014;46(10):3575–9.

    Article  CAS  PubMed  Google Scholar 

  15. Jeng EI, Miller AH, Friedman J, Tapia-Ruano SA, Reilly K, Parker A, et al. Ventricular assist device implantation and bariatric surgery: a route to transplantation in morbidly obese patients with end-stage heart failure. ASAIO J. 2020;Publish Ahead of Print. https://doi.org/10.1097/MAT.0000000000001212.

  16. Kiernan MS, Sundareswaran KS, Pham DT, Kapur NK, Pereira NL, Strueber M, et al. Preoperative determinants of quality of life and functional capacity response to left ventricular assist device therapy. J Card Fail. 2016;22(10):797–805.

    Article  PubMed  Google Scholar 

  17. • Jaiswal A, Le Jemtel TH, Samson R, Mancini D. Sustained cardiac recovery hinges on timing and natural history of underlying condition. AM J Med Sci. 2018;356(1):47–55 Comprehensive review of the cardiac recovery in advanced heart failure.

    Article  PubMed  Google Scholar 

  18. Dimopoulos S, Diakos N, Tseliou E, Tasoulis A, Mpouchla A, Manetos C, et al. Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation. Pacing Clin Electrophysiol. 2011;34(12):1607–14.

    Article  PubMed  Google Scholar 

  19. Jung MH, Gustafsson F. Exercise in heart failure patients supported with a left ventricular assist device. J Heart Lung Transplant. 2015;34(4):489–96.

    Article  PubMed  Google Scholar 

  20. Lee S, Kamdar F, Madlon-Kay R, Boyle A, Colvin-Adams M, Pritzker M, et al. Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. J Heart Lung Transplant. 2010;29(2):209–15.

    Article  PubMed  Google Scholar 

  21. Vest AR, Chan M, Deswal A, Givertz MM, Lekavich C, Lennie T, et al. Nutrition, obesity, and cachexia in patients with heart failure: a consensus statement from the Heart Failure Society of America scientific statements committee. J Card Fail. 2019;25(5):380–400.

    Article  PubMed  Google Scholar 

  22. Tsai AG, Wadden TA. The evolution of very-low-calorie diets: an update and meta-analysis. Obesity (Silver Spring). 2006;14(8):1283–93.

    Article  Google Scholar 

  23. Petroni ML, Caletti MT, Dalle Grave R, Bazzocchi A, Aparisi Gomez MP, Marchesini G. Prevention and treatment of sarcopenic obesity in women. Nutrients. 2019;11(6):1302.

    Article  CAS  PubMed Central  Google Scholar 

  24. Kerrigan DJ, Williams CT, Ehrman JK, Saval MA, Bronsteen K, Schairer JR, et al. Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the rehab-VAD randomized controlled trial. JACC Heart Fail. 2014;2(6):653–9.

    Article  PubMed  Google Scholar 

  25. Marko C, Danzinger G, Kaferback M, Lackner T, Muller R, Zimpfer D, et al. Safety and efficacy of cardiac rehabilitation for patients with continuous flow left ventricular assist devices. Eur J Prev Cardiol. 2015;22(11):1378–84.

    Article  PubMed  Google Scholar 

  26. •• Bachmann JM, Duncan MS, Shah AS, Greevy RA Jr, Lindenfeld J, Keteyian SJ, et al. Association of cardiac rehabilitation with decreased hospitalizations and mortality after ventricular assist device implantation. JACC Heart Fail. 2018;6(2):130–9 This study demonstrates the importance of cardiac rehabilitation in management of obese patients with heart failure to improve morbidity and mortality.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chu P, Gotink RA, Yeh GY, Goldie SJ, Hunink MG. The effectiveness of yoga in modifying risk factors for cardiovascular disease and metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2016;23(3):291–307.

    Article  PubMed  Google Scholar 

  28. Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013;88(3):251–8.

    Article  PubMed  Google Scholar 

  29. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–604.

    Article  CAS  PubMed  Google Scholar 

  31. • Force USPST, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(11):1163–71 This statement outlines the evidence and recommendations on behavioural interventions in the management of obesity.

    Article  Google Scholar 

  32. Greenway FL, Aronne LJ, Raben A, Astrup A, Apovian CM, Hill JO, et al. A randomized, double-blind, placebo-controlled study of Gelesis100: a novel nonsystemic oral hydrogel for weight loss. Obesity (Silver Spring). 2019;27(2):205–16.

    Article  CAS  Google Scholar 

  33. Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zaccardi F, Webb DR, Htike ZZ, Youssef D, Khunti K, Davies MJ. Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis. Diabetes Obes Metab. 2016;18(8):783–94.

    Article  CAS  PubMed  Google Scholar 

  35. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311(1):74–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. • May M, Schindler C, Engeli S. Modern pharmacological treatment of obese patients. Ther Adv Endocrinol Metab. 2020;11:1–19 Comprehensive review of anti-obesity drugs.

    Article  CAS  Google Scholar 

  37. Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387(10031):1947–56.

    Article  PubMed  Google Scholar 

  38. American College of Cardiology/American Heart Association Task Force on Practice Guidelines OEP. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the The Obesity Expert Panel, 2013. Obesity (Silver Spring). 2014;22(Suppl 2):S5–S39.

    Google Scholar 

  39. Vest AR, Patel P, Schauer PR, Satava ME, Cavalcante JL, Brethauer S, et al. Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction. Circ Heart Fail. 2016;9(3):e002260.

    Article  PubMed  Google Scholar 

  40. Sidhu GS, Samson R, Ayinapudi K, Le Jemtel TH. Bariatric surgery and hospitalization for heart failure in morbidly obese patients. Obes Surg. 2020;30(11):4218–25.

    Article  PubMed  Google Scholar 

  41. Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes. Obes Surg. 2016;26(5):1030–40.

    Article  PubMed  Google Scholar 

  42. Alpert MA, Pritchett AM. Bariatric surgery in patients with left ventricular systolic dysfunction: effective, but is it safe? Circ Heart Fail. 2016;9(3):e002960.

    Article  PubMed  Google Scholar 

  43. Vest AR, Schauer PR, Young JB. Failure and fatness: could surgical management of obesity reduce heart failure hospitalizations? J Am Coll Cardiol. 2016;67(8):904–6.

    Article  PubMed  Google Scholar 

  44. Netto BD, Bettini SC, Clemente AP, Ferreira JP, Boritza K, Souza Sde F, et al. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg. 2015;25(6):1010–8.

    Article  PubMed  Google Scholar 

  45. • Gottdiener JS, Kop WJ. Body and heart: effects of weight gain and loss on left ventricular size and function. Circ Cardiovasc Imaging. 2017;10(3):e006084 This study highlights the benefits of weight loss on cardiac reverse remodeling.

    Article  PubMed  Google Scholar 

  46. Hoefnagel AL, Pasternak R, Curle AE, Eaton MP. Laparoscopic gastric bypass in a patient with an implanted left ventricular assist device. J Cardiothorac Vasc Anesth. 2012;26(5):880–2.

    Article  PubMed  Google Scholar 

  47. Ahmed M, Le H, Aranda JM Jr, Klodell CT. Elective noncardiac surgery in patients with left ventricular assist devices. J Card Surg. 2012;27(5):639–42.

    Article  PubMed  Google Scholar 

  48. Gill RS, Karmali S, Nagandran J, Frazier HO, Sherman V. Combined ventricular assist device placement with adjustable gastric band (VAD-BAND): a promising new technique for morbidly obese patients awaiting potential cardiac transplantation. J Clin Med Res. 2012;4(2):127–9.

    PubMed  PubMed Central  Google Scholar 

  49. Saeed D, Meehan K, McGee EC Jr. Bariatric surgery at the time of ventricular assist device implantation for morbidly obese patients prior to heart transplantation. Artif Organs. 2012;36(4):450–1.

    Article  PubMed  Google Scholar 

  50. Caceres M, Czer LS, Esmailian F, Ramzy D, Moriguchi J. Bariatric surgery in severe obesity and end-stage heart failure with mechanical circulatory support as a bridge to successful heart transplantation: a case report. Transplant Proc. 2013;45(2):798–9.

    Article  CAS  PubMed  Google Scholar 

  51. DeNino WF, Peura JL, Toole JM. Orthotopic heart transplantation after left ventricular assist device implantation and laparoscopic Roux-en-Y gastric bypass. J Heart Lung Transplant. 2013;32(3):377–8.

    Article  PubMed  Google Scholar 

  52. Kanji A, Mikami DJ, Ravi Y, Sai-Sudhakar CB, Higgins RS, Needleman BJ. Laparascopic sleeve gastrectomy in patients with end stage heart failure can be performed safely and is an effective method of weight loss for symtom improvement and access to cardiac transplantation. Surg Endosc. 2013;27(1):S433.

    Google Scholar 

  53. Lockard KL, Allen C, Lohmann D, Severyn DA, Schaub RD, Kauffman KE, et al. Bariatric surgery for a patient with a HeartMate II ventricular assist device for destination therapy. Prog Transplant. 2013;23(1):28–32.

    Article  PubMed  Google Scholar 

  54. Leviner DB, Keidar A, Ben-Gal T, Medalion B. Cardiac function recovery following LVAD implantation and bariatric surgery in a morbidly obese patient. J Card Surg. 2014;29(5):740–2.

    Article  PubMed  Google Scholar 

  55. Wikiel KJ, McCloskey CA, Ramanathan RC. Bariatric surgery: a safe and effective conduit to cardiac transplantation. Surg Obes Relat Dis. 2014;10(3):479–84.

    Article  PubMed  Google Scholar 

  56. Prathanvanich P, Chand B. Laparoscopic vertical sleeve gastrectomy (LVSG) in a patient with dilated cardiomyopathy with a left ventricular assist device (LVAD). Surg Endosc. 2014;28(1):446–69.

    Google Scholar 

  57. Morrow EH, Pellegrini CA, Mokadam NA, Khandelwal S. Laparoscopic gastric bypass during left ventricular assist device support and ventricular recovery. J Heart Lung Transplant. 2014;33(8):870–1.

    Article  PubMed  Google Scholar 

  58. Chaudhry UI, Kanji A, Sai-Sudhakar CB, Higgins RS, Needleman BJ. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis. 2015;11(1):88–93.

    Article  PubMed  Google Scholar 

  59. Amro A, Murr M. A video case report of LRYGB in a patient with a left ventricular assist device. Surg Obes Relat Dis. 2015;11(6):1406–7.

    Article  PubMed  Google Scholar 

  60. Shah SK, Gregoric ID, Nathan SS, Akkanti BH, Kar B, Bajwa KS, et al. Simultaneous left ventricular assist device placement and laparoscopic sleeve gastrectomy as a bridge to transplant for morbidly obese patients with severe heart failure. J Heart Lung Transplant. 2015;34(11):1489–91.

    Article  PubMed  Google Scholar 

  61. Zolty R, Um J, Raichlin E, Vongooru H, Burdorf AF, Ryan TR, et al. Abstract 16793: Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and LVAD. Circulation. 2016;134(suppl_1):A16793-A.

    Google Scholar 

  62. George SC, Phancao AA, Karia DH, Sasevich MJ, Wright HC, Le HS, et al. Laparoscopic sleeve gastrectomy: safe and effective in heart failure and LVAD patients. J Heart Lung Transplant. 2016;35(4):S19.

    Article  Google Scholar 

  63. Jeng EI, Aranda JM Jr, Ahmed M, Klodell CT. Left ventricular assist device and bariatric surgery: a bridge to heart transplant by weight and waiting time reduction. J Card Surg. 2016;31(2):120–2.

    Article  PubMed  Google Scholar 

  64. Greene J, Tran T, Shope T. Sleeve gastrectomy and left ventricular assist device for heart transplant. JSLS. 2017;21(3).

  65. Friedman J, Shores J. Laparoscopic sleeve gastrectomy in morbidly obese patients with end stage heart failure on circulatory support as a bridge to transplant. Obes Surg. 2017;27(1):294.

    Google Scholar 

  66. Becker CA, Mendenhall MD, George S, Jacob T, Patrick A, Duke M, et al. Bariatric surgery in morbidly obese advanced heart fialure patients. J Am Coll Cardiol. 2018;71(11_Supplement):A2127-A.

    Article  Google Scholar 

  67. Gregoric ID, Radovancevic R, Patel MK, Jezovnik MK, Nathan SS, Akkanti BH, et al. Laparoscopic sleeve gastrectomy in morbidly obese patients undergoing left ventricular assist device implantation. J Heart Lung Transplant. 2018;37(4):S277.

    Article  Google Scholar 

  68. Pullatt R, Crowley NM, Byrne KT, Axiotis D. Bariatric surgery as a bridge to cardiac transplantation in patients with LVAD. Surg Obes Relat Dis. 2018;14(11):S121–S2.

    Article  Google Scholar 

  69. Donohoe CL, Mattar SG, Spight D, Husain FA. Laparoscopic sleeve gastrectomy as a bridge to cardiac transplantation. Surg Endosc. 2018;32(1):S300.

    Google Scholar 

  70. Christophy A, Bhoyrul S, Srivastava A, Heywood JT, Mohan R. The use of bariatric surgery in patients with left ventricular assist devices to expedite heart transplant candidacy. J Card Fail. 2018;24(8):S123.

    Article  Google Scholar 

  71. Lamba HK, Santiago A, Kurihara C, Kawabori M, Sugiura T, Eskew J, et al. Bariatric surgery in patients with continuous flow left ventricular assist devices. J Heart Lung Transplant. 2018;37(4):S385–S6.

    Article  Google Scholar 

  72. • Yang TWW, Johari Y, Burton PR, Earnest A, Shaw K, Hare JL, et al. Bariatric surgery in patients with severe heart failure. Obes Surg. 2020;30(8):2863–9 Latest case-series of successful heart transplantation and myocardial recovery after bariatric surgery in patients with heart failure.

    Article  PubMed  Google Scholar 

  73. Morrison SA, Vest A, Schumman R, Shah SN. The efficacy of laparoscopic sleeve gastrectomy as a bridge to transplantation in patients with advanced heart failure. Surg Endosc. 2018;32(1):S303.

    Google Scholar 

  74. Hawkins RB, Go K, Raymond SL, Ayzengart A, Friedman J. Laparoscopic sleeve gastrectomy in patients with heart failure and left ventricular assist devices as a bridge to transplant. Surg Obes Relat Dis. 2018;14(9):1269–73.

    Article  PubMed  Google Scholar 

  75. Kumar S, Nathan S, Jumean M, Akkanti B, Hussain R, Shah S, et al. Bariatric surgery in advanced heart failure patients provides bridge to definitive therapy. J Am Coll Cardiol. 2018;71(11_Supplement):A676-A.

    Article  Google Scholar 

  76. Punchai S, Nor Hanipah Z, Sharma G, Aminian A, Steckner K, Cywinski J, et al. Laparoscopic sleeve gastrectomy in heart failure patients with left ventricular assist device. Obes Surg. 2019;29(4):1122–9.

    Article  PubMed  Google Scholar 

  77. Poglajen G, Kumar S, Akkanti B, Radovancevic R, Nathan S, Jumean M, et al. The combination of left ventricular assist device and laparoscopic sleeve gastrectomy may promote myocardial recovery in obese advanced chronic heart failure patients. J Heart Lung Transplant. 2019;38(4):S81–S2.

    Article  Google Scholar 

  78. Aittigrine S, Tozzi P, Hullin R, Yerly P, Regamey J, Rosner L, et al. Laparoscopic sleeve gastrectomy for class III obesity in a patient with a left ventricular assist device (LVAD) Heartmate III. Surg Obes Relat Dis. 2019;15(8):1420–1.

    Article  PubMed  Google Scholar 

  79. Mantziari S, Aittigrine S, Favre L, Regamey J, Rösner L, Kirsch M, et al. Sleeve gastrectomy in a patient with a left ventricular assist device (LVAD) as a bridge to transplantation. Obes Surg. 2019;29(5):491.

    Google Scholar 

  80. Camuso JM, Coglianese E, Thomas S, D'Alessandro D, Lewis G, Milley K, et al. Getting back on the list: development of guidelines for bariatric surgery in patients with LVADs. J Heart Lung Transplant. 2020;39(4):S494–S5.

    Article  Google Scholar 

  81. Van Aelst P, Deleus E, Van der Schueren B, Meyns B, Vandersmissen K, Lannoo M. Laparoscopic sleeve gastrectomy in patients with left ventricular assist device-case series and review of literature. Obes Surg. 2020;30(9):3628–33.

    Article  PubMed  Google Scholar 

  82. Val FRD, Cheon O, Menser T, Kash B, Jones SL, Baek J, et al. Bariatric surgery in end-stage heart failure: feasibility in successful attainment of a target body mass index. J Card Fail 2020: S1071-9164 (19)31761–0.

  83. da Silva-deAbreu A, Garikapati K, Alhafez BA, Desai S, Eiswirth C, Krim S, et al. Laparoscopic sleeve gastrectomy in patients with obesity and ventricular assist devices: a comprehensive outcome analysis. Obes Surg. 2020. https://doi.org/10.1007/s11695-020-04948-9.

  84. Douglas IJ, Bhaskaran K, Batterham RL, Smeeth L. Bariatric surgery in the United Kingdom: a cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med. 2015;12(12):e1001925.

    Article  PubMed  PubMed Central  Google Scholar 

  85. • Celio AC, Wu Q, Kasten KR, Manwaring ML, Pories WJ, Spaniolas K. Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients. Surg Endosc. 2017;31(1):317–23 This study assesses the comparative effectiveness of two of the most common bariatric procedures- Roux-en-Y gastric bypass and sleeve gastrectomy in patients with severe obesity.

    Article  PubMed  Google Scholar 

  86. Nguyen NT, Nguyen B, Gebhart A, Hohmann S. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216(2):252–7.

    Article  PubMed  Google Scholar 

  87. Rogers CC, Alloway RR, Alexander JW, Cardi M, Trofe J, Vinks AA. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transpl. 2008;22(3):281–91.

    Article  Google Scholar 

  88. Parikh M, Issa R, McCrillis A, Saunders JK, Ude-Welcome A, Gagner M. Surgical strategies that may decrease leak after laparoscopic sleeve gastrectomy: a systematic review and meta-analysis of 9991 cases. Ann Surg. 2013;257(2):231–7.

    Article  PubMed  Google Scholar 

  89. Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008;31(11):516–20.

    Article  PubMed  PubMed Central  Google Scholar 

  90. • Challapalli J, Maynes EJ, O'Malley TJ, Cross DE, Weber MP, Choi JH, et al. Sleeve gastrectomy in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Obes Surg. 2020;30(11):4437–45 This meta analysis evaluated the outcome of bariatric surgery in patients with left ventricular assist devices. Also discussed staged/simultaneous procedures with no significant difference in post operative outcomes of both.

    Article  PubMed  Google Scholar 

  91. Apovian CM, Shah SN, Wolfe BM, Ikramuddin S, Miller CJ, Tweden KS, et al. Two-year outcomes of vagal nerve blocking (vBloc) for the treatment of obesity in the ReCharge trial. Obes Surg. 2017;27(1):169–76.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abhishek Jaiswal.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gadela, N.V., Umashanker, D., Scatola, A. et al. Clinical Outcomes, Trends in Weight, and Weight Loss Strategies in Patients With Obesity After Durable Ventricular Assist Device Implantation. Curr Heart Fail Rep 18, 52–63 (2021). https://doi.org/10.1007/s11897-020-00500-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-020-00500-z

Keywords

Navigation